TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer

NCT03720431 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: TTAC-0001 and pembrolizumab combination

Sponsor

PharmAbcine